Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement - FactEntry
Drug maker Teva agrees to $4.3 billion national settlement over opioid lawsuits - MarketWatch
Israel's Teva Pharmaceuticals Seeks Buyer for Its Medis Unit to Raise Cash - Business - Haaretz.com
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters")
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem Post
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Can Teva's Debt Repayment Plan Deleverage Its Balance Sheet?
Billionaire Businessman Looking to Take Stake in Debt-Ridden Teva | BioSpace
Troubled Drugmaker Teva to Axe over 4,000 Jobs | Ctech
Teva's Working With Evercore to Review Debt Options - Bloomberg
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026
Teva Pharmaceutical Industries - GuruFocus.com
Teva Pharmaceutical Industries Stock Is Estimated To Be Fairly Valued
Teva to shut Ashdod plant within year, with loss of 175 jobs | The Times of Israel
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
